Immunitas Therapeutics (“Immunitas”), an innovative single cell genomics discovery platform company focused on developing breakthrough immuno-oncology therapies, today announced it has appointed Jeffrey M. Goldberg as Chief Executive Officer and Director. He succeeds founding CEO, Christoph Westphal, M.D, Ph.D., who assumes the role of Chairman of the Board of Directors.

https://www.businesswire.com/news/home/20191218005153/en/Jeffrey-Goldberg-Appointed-Chief-Executive-Officer-Director